Richard Goldberg
May 14, 2025, 11:10
Agenus Welcomes Richard Goldberg as Chief Development Officer
Agenus shared a post on LinkedIn:
“We are pleased to welcome Dr. Richard Goldberg to Agenus as Chief Development Officer.
A pioneer in gastrointestinal oncology, Dr. Goldberg brings decades of experience and has made significant contributions through clinical practice, research, and leadership.
His expertise will guide the advancement of our immuno-oncology programs and support our mission to improve outcomes for patients with hard-to-treat cancers.
Read the full announcement.”
Richard Goldberg joins Agenus as Chief Development Officer. His leadership and background in gastrointestinal oncology will help guide the company’s immuno-oncology initiatives and patient-focused development efforts.
More posts featuring Agenus.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 14, 2025, 12:22
May 14, 2025, 11:10
May 14, 2025, 11:00
May 14, 2025, 10:45